BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 27221263)

  • 1. Sustained-release dexamethasone intravitreal implant in juvenile idiopathic arthritis-related uveitis.
    Pichi F; Nucci P; Baynes K; Lowder CY; Srivastava SK
    Int Ophthalmol; 2017 Feb; 37(1):221-228. PubMed ID: 27221263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PROSPECTIVE EVALUATION OF A SUSTAINED-RELEASE DEXAMETHASONE INTRAVITREAL IMPLANT FOR CYSTOID MACULAR EDEMA IN QUIESCENT UVEITIS.
    Khurana RN; Bansal AS; Chang LK; Palmer JD; Wu C; Wieland MR
    Retina; 2017 Sep; 37(9):1692-1699. PubMed ID: 27893624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of dexamethasone implant along with phacoemulsification and intraocular lens implantation in children with juvenile idiopathic arthritis associated uveitis.
    Jinagal J; Gupta G; Agarwal A; Aggarwal K; Akella M; Gupta V; Suri D; Gupta A; Singh S; Ram J
    Indian J Ophthalmol; 2019 Jan; 67(1):69-74. PubMed ID: 30574896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexamethasone intravitreal implant (Ozurdex®) for pediatric uveitis.
    Sella R; Oray M; Friling R; Umar L; Tugal-Tutkun I; Kramer M
    Graefes Arch Clin Exp Ophthalmol; 2015 Oct; 253(10):1777-82. PubMed ID: 26228441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluocinolone acetonide intravitreal implant (Retisert
    Leinonen S; Immonen I; Kotaniemi K
    Acta Ophthalmol; 2018 Sep; 96(6):648-651. PubMed ID: 29655222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystoid macular edema associated with juvenile idiopathic arthritis resolved by a dexamethasone intravitreal implant.
    Totan Y; Güler E; Guragaç FB; Dervisogullari MS; Tenlik A; Hepsen IF
    J Pediatr Ophthalmol Strabismus; 2014 May; 51 Online():e25-8. PubMed ID: 24811080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexamethasone Intravitreal Implant Injection in Eyes with Comorbid Hypotony.
    Kong X; Psaras C; Stewart JM
    Ophthalmol Retina; 2019 Nov; 3(11):993-997. PubMed ID: 31371197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal Dexamethasone Implant for Treatment of Sarcoidosis-Related Uveitis.
    Kim M; Kim SA; Park W; Kim RY; Park YH
    Adv Ther; 2019 Aug; 36(8):2137-2146. PubMed ID: 31140122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.
    Coscas G; Coscas F; Zucchiatti I; Glacet-Bernard A; Soubrane G; Souïed E
    Eur J Ophthalmol; 2011; 21(5):631-6. PubMed ID: 21500185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EFFICACY AND SAFETY OF DEXAMETHASONE INTRAVITREAL IMPLANT FOR PERSISTENT UVEITIC CYSTOID MACULAR EDEMA.
    Khurana RN; Porco TC
    Retina; 2015 Aug; 35(8):1640-6. PubMed ID: 25741813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal Dexamethasone Implant for the Treatment of Macular Edema in Chronic Non-infectious Uveitis.
    Tsang AC; Virgili G; Abtahi M; Gottlieb CC
    Ocul Immunol Inflamm; 2017 Oct; 25(5):685-692. PubMed ID: 27191685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Non-infectious Uveitic Macular Edema with the Intravitreal Dexamethasone Implant.
    Nobre-Cardoso J; Champion E; Darugar A; Fel A; Lehoang P; Bodaghi B
    Ocul Immunol Inflamm; 2017 Aug; 25(4):447-454. PubMed ID: 27003221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexamethasone Intravitreal Implant in the Treatment of Uveitic Macular Edema in the Perioperative Cataract Setting: A Case Series.
    Larochelle MB; Smith J; Dacey MS
    Am J Ophthalmol; 2016 Jun; 166():149-153. PubMed ID: 27066725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal Dexamethasone Implant in the Treatment of Non-infectious Uveitis.
    Hasanreisoğlu M; Özdemir HB; Özkan K; Yüksel M; Aktaş Z; Atalay HT; Özdek Ş; Gürelik G
    Turk J Ophthalmol; 2019 Oct; 49(5):250-257. PubMed ID: 31650791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal Dexamethasone Implant as an Adjunct Weapon for Severe and Refractory Uveitis in Behçet's Disease.
    Fabiani C; Emmi G; Lopalco G; Vannozzi L; Bacherini D; Guerriero S; Franceschini R; Frediani B; Iannone F; Marco Tosi G; Rigante D; Cantarini L
    Isr Med Assoc J; 2017 Jul; 19(7):415-419. PubMed ID: 28786255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Efficacy of Intravitreal Dexamethasone Implant for Refractory Uveitic Macular Edema in Adults and Children.
    Ratra D; Barh A; Banerjee M; Ratra V; Biswas J
    Ocul Immunol Inflamm; 2018; 26(7):1034-1040. PubMed ID: 29394119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DEXAMETHASONE INTRAVITREAL IMPLANT FOR THE TREATMENT OF RECALCITRANT MACULAR EDEMA AFTER RHEGMATOGENOUS RETINAL DETACHMENT REPAIR.
    Thanos A; Todorich B; Yonekawa Y; Papakostas TD; Khundkar T; Eliott D; Dass AB; Williams GA; Capone A; Faia LJ; Wolfe JD; Hassan TS; Ruby AJ
    Retina; 2018 Jun; 38(6):1084-1090. PubMed ID: 28622270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of an intravitreal dexamethasone implant for the treatment of noninfectious uveitic macular edema.
    Habot-Wilner Z; Sorkin N; Goldenberg D; Loewenstein A; Goldstein M
    Ophthalmologica; 2014; 232(2):77-82. PubMed ID: 25012541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone intravitreal implant for treatment of uveitic persistent cystoid macular edema in vitrectomized patients.
    Adán A; Pelegrín L; Rey A; Llorenç V; Mesquida M; Molins B; Ríos J; Keller J
    Retina; 2013; 33(7):1435-40. PubMed ID: 23514796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal Sustained-Release Steroid Implants for the Treatment of Macular Edema following Surgical Removal of Epiretinal Membranes.
    Hattenbach LO; Springer-Wanner C; Hoerauf H; Callizo J; Jungmann S; Brauns T; Fulle G; Eichel S; Koss MJ; Kuhli-Hattenbach C
    Ophthalmologica; 2017; 237(4):232-237. PubMed ID: 28463851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.